title: Rosiglitazone, medical reversal, and back to basics for diabetes.
authors.affiliation: Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
authors.forename: Vinay
authors.initials: V
authors.lastname: Prasad
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000139:chemically induced / Q000517:prevention & control; D010818:Practice Patterns, Physicians'; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D008687:Metformin